Solventum Corporation (SOLV) Tuesday said that it has completed the sale of its Purification & Filtration business to Thermo Fisher Scientific Inc. (TMO) for $4 billion in cash.
As previously announced, the company plans to use the net proceeds of $3.4 billion primarily to pay down debts.
Additionally, Solventum has updated its full-year outlook to reflect the partial year increase of the accelerated divestiture of Purification & Filtration business.
Solventum currently expects adjusted EPS to be in the range of $5.88 - $6.03, up from the previous outlook of $5.80 - $5.95.
Analysts on average expect the company to report earnings of $5.88 per share for the year. Analysts' estimates typically exclude special items.
The company continues to expect organic sales growth of 2%-3%.
For comments and feedback contact: editorial@rttnews.com
Business News
May 01, 2026 15:54 ET Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.